英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：

surmountable    
a. 可战胜的,可克服的,可凌驾的

可战胜的,可克服的,可淩驾的

surmountable
adj 1: capable of being surmounted or overcome; "situations of
measurable and surmountable danger" [ant:
{insurmountable}, {unsurmountable}]
2: capable of being surmounted [synonym: {surmountable},
{climbable}]

Surmountable \Sur*mount"a*ble\, a. [Cf. F. surmontable.]
Capable of being surmounted or overcome; superable. --
{Sur*mount"a*ble*ness}, n.
[1913 Webster]


请选择你想看的字典辞典：
单词字典翻译
surmountable查看　surmountable　在百度字典中的解释百度英翻中〔查看〕
surmountable查看　surmountable　在Google字典中的解释Google英翻中〔查看〕
surmountable查看　surmountable　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • label - Food and Drug Administration
    TZIELD is a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes (T1D) in adults and pediatric patients aged 8 years and older with Stage 2 T1D (1)
  • HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include . . .
    INDICATIONS AND USAGE TZIELD is indicated to delay the onset of Stage 3 type 1 diabetes (T1D) in adult and pediatric patients 1 year of age and older with Stage 2 type 1 diabetes [see Dosage and Administration (2 1)]
  • TZIELD. com | For US Consumers
    TZIELD is a prescription medicine used to delay the onset of Stage 3 type 1 diabetes, which is when your body cannot make enough insulin on its own and may require insulin injections
  • Tzield Injection: Package Insert Prescribing Info
    Tzield Injection package insert prescribing information for healthcare professionals Includes: indications, dosage, adverse reactions and pharmacology
  • HIGHLIGHTS OF PRESCRIBING INFORMATION 窶披 披 披 披 披 披 披 披 披 ・WARNINGS AND . . .
    1 INDICATIONS AND USAGE TZIELD is indicated to delay the onset of Stage 3 type 1 diabetes in adults and pediatric patients 8 years of age and older with Stage 2 type 1 diabetes [see Dosage and Administration (2 1)]
  • TZIELD - sanofimarketaccess. com
    TZIELD® (teplizumab-mzwv) is a CD3-directed monoclonal antibody indicated to delay the onset of Stage 3 type 1 diabetes (T1D) in adults and pediatric patients aged 8 years and older with Stage 2 T1D
  • TZIELD (Provention Bio, Inc. ): FDA Package Insert
    TZIELD is indicated to delay the onset of Stage 3 type 1 diabetes in adults and pediatric patients 8 years of age and older with Stage 2 type 1 diabetes [see Dosage and Administration (2 1)]
  • TZIELD DailyMed Label - FDA. report
    TZIELD is received as an infusion one-time a day, every day, for 14 days Each TZIELD infusion will last at least 30 minutes if you are an adult or your child is 8 years of age or older Each TZIELD infusion will last at least 2 hours if your child is 1 to less than 8 years of age
  • TZIELD API - campus. sanofi
    USAGE: TZIELD is a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes (T1D) in adults and pediatric patients aged 8 years and older with Stage 2 T1D
  • TZIELD - medsinfo. com. au
    Tzield is indicated to delay the onset of Stage 3 type 1 diabetes mellitus (T1D) in adult and paediatric patients aged 8 years and older with Stage 2 type 1 diabetes mellitus (see Section 5 1 Pharmacodynamic Properties – Clinical trials)





中文字典-英文字典  2005-2009